Eversept Partners as of June 30, 2024
Portfolio Holdings for Eversept Partners
Eversept Partners holds 74 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 9.4 | $137M | 286k | 479.11 | |
| GSK Sponsored Adr (GSK) | 9.1 | $134M | 3.5M | 38.50 | |
| Natera (NTRA) | 8.7 | $127M | 1.2M | 108.29 | |
| Insmed Com Par $.01 (INSM) | 5.3 | $77M | 1.2M | 67.00 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 5.3 | $77M | 4.7M | 16.25 | |
| United Therapeutics Corporation (UTHR) | 5.1 | $75M | 235k | 318.55 | |
| Syndax Pharmaceuticals (SNDX) | 5.1 | $74M | 3.6M | 20.53 | |
| Vera Therapeutics Cl A (VERA) | 5.1 | $74M | 2.0M | 36.18 | |
| Inspire Med Sys (INSP) | 4.9 | $71M | 533k | 133.83 | |
| PerkinElmer (RVTY) | 3.2 | $47M | 452k | 104.86 | |
| Hca Holdings (HCA) | 3.0 | $44M | 136k | 321.28 | |
| Bio-techne Corporation (TECH) | 2.7 | $39M | 543k | 71.65 | |
| Healthequity (HQY) | 2.4 | $36M | 414k | 86.20 | |
| Community Health Systems (CYH) | 1.8 | $27M | 8.0M | 3.36 | |
| Repligen Corporation (RGEN) | 1.7 | $25M | 194k | 126.06 | |
| Celldex Therapeutics Com New (CLDX) | 1.6 | $23M | 633k | 37.01 | |
| Ionis Pharmaceuticals (IONS) | 1.5 | $22M | 457k | 47.66 | |
| Novo-nordisk A S Adr (NVO) | 1.4 | $21M | 147k | 142.74 | |
| Eli Lilly & Co. (LLY) | 1.3 | $19M | 21k | 905.38 | |
| Protagonist Therapeutics (PTGX) | 1.2 | $18M | 506k | 34.65 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 1.1 | $17M | 31k | 544.22 | |
| Argenx Se Sponsored Adr (ARGX) | 1.0 | $15M | 35k | 430.04 | |
| Humana (HUM) | 1.0 | $14M | 38k | 373.65 | |
| Viatris (VTRS) | 1.0 | $14M | 1.3M | 10.63 | |
| Zimvie (ZIMV) | 1.0 | $14M | 768k | 18.25 | |
| Mannkind Corp Com New (MNKD) | 0.8 | $12M | 2.3M | 5.22 | |
| Brookdale Senior Living (BKD) | 0.7 | $11M | 1.5M | 6.83 | |
| Danaher Corporation (DHR) | 0.7 | $10M | 41k | 249.85 | |
| Spdr Ser Tr S&p Biotech (XBI) | 0.6 | $9.3M | 100k | 92.71 | |
| Travere Therapeutics (TVTX) | 0.6 | $9.0M | 1.1M | 8.22 | |
| Anthem (ELV) | 0.5 | $7.9M | 15k | 541.86 | |
| Arcutis Biotherapeutics (ARQT) | 0.5 | $7.8M | 838k | 9.30 | |
| Centene Corporation (CNC) | 0.5 | $7.7M | 116k | 66.30 | |
| Miragen Therapeutics (VRDN) | 0.5 | $7.4M | 568k | 13.01 | |
| Viking Therapeutics (VKTX) | 0.5 | $7.3M | 139k | 53.01 | |
| Vaxcyte (PCVX) | 0.5 | $7.3M | 96k | 75.51 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $7.1M | 1.2M | 6.18 | |
| Cytokinetics Com New (CYTK) | 0.5 | $6.9M | 127k | 54.18 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.4 | $6.3M | 330k | 19.21 | |
| Evolus (EOLS) | 0.4 | $6.2M | 575k | 10.85 | |
| Molina Healthcare (MOH) | 0.4 | $5.4M | 18k | 297.30 | |
| Sutro Biopharma (STRO) | 0.3 | $5.1M | 1.7M | 2.93 | |
| Gossamer Bio (GOSS) | 0.3 | $4.9M | 5.5M | 0.90 | |
| Oscar Health Cl A (OSCR) | 0.3 | $4.9M | 311k | 15.82 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.3 | $4.5M | 110k | 40.89 | |
| Liquidia Corporation Com New (LQDA) | 0.3 | $4.5M | 374k | 12.00 | |
| Myriad Genetics (MYGN) | 0.3 | $4.5M | 182k | 24.46 | |
| Puma Biotechnology (PBYI) | 0.3 | $4.3M | 1.3M | 3.26 | |
| Karyopharm Therapeutics | 0.3 | $4.3M | 5.0M | 0.87 | |
| 2seventy Bio Common Stock | 0.3 | $4.3M | 1.1M | 3.85 | |
| Nevro (NVRO) | 0.3 | $4.2M | 499k | 8.42 | |
| Icon SHS (ICLR) | 0.3 | $4.0M | 13k | 313.47 | |
| Merus N V (MRUS) | 0.3 | $3.9M | 67k | 59.17 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.2 | $3.1M | 72k | 43.97 | |
| Amarin Corp Spons Adr New | 0.2 | $3.0M | 4.3M | 0.69 | |
| Guardant Health (GH) | 0.2 | $2.9M | 99k | 28.88 | |
| Inflarx Nv (IFRX) | 0.2 | $2.7M | 1.6M | 1.74 | |
| Avantor (AVTR) | 0.2 | $2.7M | 125k | 21.20 | |
| Tourmaline Bio (TRML) | 0.2 | $2.6M | 205k | 12.86 | |
| Iqvia Holdings (IQV) | 0.2 | $2.6M | 12k | 211.44 | |
| Alector (ALEC) | 0.2 | $2.5M | 542k | 4.54 | |
| Immunovant (IMVT) | 0.2 | $2.5M | 93k | 26.40 | |
| Xoma Corp Del Com New (XOMA) | 0.1 | $2.2M | 92k | 23.69 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $2.1M | 611k | 3.48 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $1.9M | 286k | 6.81 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $1.8M | 496k | 3.60 | |
| Kura Oncology (KURA) | 0.1 | $1.5M | 72k | 20.59 | |
| Absci Corp (ABSI) | 0.1 | $1.0M | 326k | 3.08 | |
| Fulcrum Therapeutics (FULC) | 0.1 | $948k | 153k | 6.20 | |
| Affimed N V Ordinary Shs New (AFMDQ) | 0.1 | $907k | 167k | 5.45 | |
| Stoke Therapeutics (STOK) | 0.1 | $828k | 61k | 13.51 | |
| G1 Therapeutics | 0.0 | $456k | 200k | 2.28 | |
| Ac Immune Sa SHS (ACIU) | 0.0 | $396k | 99k | 3.99 | |
| Seres Therapeutics | 0.0 | $303k | 418k | 0.72 |